Tracing Antimicrobial Resistance Across the Hospital–Wastewater–River Continuum: A Pre-COVID-19 and Pandemic-Era Study in Bucharest, Romania
Environments · 29.10.2026 · 13 (11) · 591
DOI: 10.3390/environments13110591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environments, online erschienen am 29.10.2026. Verfasst von Ecaterina Monica Sarbu und 14 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian National Authority for Scientific Research, clinical sector, ARES.
Abstract (Originalsprache)
Hospital and municipal wastewaters can transport antimicrobial-resistant bacteria from human-associated sources into receiving aquatic environments, yet longitudinal evidence of their occurrence across the COVID-19 transition remains limited in Eastern Europe. We analyzed seven Bucharest-area sampling campaigns from June 2019 to March 2021 across hospital wastewater, the Glina municipal wastewater treatment plant (WWTP), and the Dâmbovița River. Culture-based abundances of extended-spectrum beta-lactamase (ESBL), carbapenem resistance (CARBA), OXA-48, and vancomycin-resistant enterococci (VRE) screening phenotypes were compared between four pre-COVID-19 and three pandemic-era campaigns. During the pandemic era, ESBL and several carbapenem-resistance screening phenotypes were detected in all three Glina effluent campaigns, whereas detection was generally intermittent before COVID-19. Under the baseline non-detect convention, median effluent abundances were 2.12–4.12 log10 units higher during the COVID-19 era for selected ESBL, CARBA, and OXA screening phenotypes. These descriptive differences were estimated from only four pre-COVID-19 and three COVID-19-era campaigns and were sensitive to assumptions regarding non-detects and sampling formats. Under the original non-detect substitution convention, median CARBA non-fermenter treatment-associated reduction decreased from 2.29 to 0.38 log10 units, while VRE showed inconsistent influent–effluent patterns, including a negative median concentration difference (−1.76 log10 units) during the pandemic era. Downstream river samples exceeded upstream levels for several phenotypes across most campaigns, whereas hospital effluent remained a high-AMR compartment without a uniform pandemic-era increase. These findings highlight municipal effluent and the receiving-water interface as important surveillance points and support integrated AMR monitoring across the urban wastewater continuum.
Förderung
- Romanian National Authority for Scientific Research
- clinical sector
- ARES
Zitieren
APA
Sarbu, E. M., Popa, M., Vrancianu, C. O., Marutescu, L. G., Barbu, I. C., Gheorghe-Barbu, I., Nita-Lazar, M., Muntean, M., Dragomirescu, C. C., Popa, G. L., Preda, M., Postolache, C., Muntean, A. A., Streinu-Cercel, A., & Popa, M. I. (2026). Tracing Antimicrobial Resistance Across the Hospital–Wastewater–River Continuum: A Pre-COVID-19 and Pandemic-Era Study in Bucharest, Romania. Environments, 13(11), 591. https://doi.org/10.3390/environments13110591
Vancouver
Sarbu EM, Popa M, Vrancianu CO, Marutescu LG, Barbu IC, Gheorghe-Barbu I, et al. Tracing Antimicrobial Resistance Across the Hospital–Wastewater–River Continuum: A Pre-COVID-19 and Pandemic-Era Study in Bucharest, Romania. Environments. 2026;13(11):591. doi:10.3390/environments13110591
BibTeX
@article{Sarbu2026,
author = {Sarbu, Ecaterina Monica and Popa, Marcela and Vrancianu, Corneliu Ovidiu and Marutescu, Luminita Gabriela and Barbu, Ilda Czobor and Gheorghe-Barbu, Irina and Nita-Lazar, Mihai and Muntean, Madalina-Maria and Dragomirescu, Cerasella Cristiana and Popa, Gabriela Loredana and Preda, Mădălina and Postolache, Carmen and Muntean, Alexandru Andrei and Streinu-Cercel, Adrian and Popa, Mircea Ioan},
title = {Tracing Antimicrobial Resistance Across the Hospital–Wastewater–River Continuum: A Pre-COVID-19 and Pandemic-Era Study in Bucharest, Romania},
journal = {Environments},
year = {2026},
volume = {13},
number = {11},
pages = {591},
doi = {10.3390/environments13110591}
}
EUVIMED